OUR INSTITUTES: CANCER | HEART | NEUROSCIENCE | ORTHOPAEDICS
 
 

Hematology / Oncology Fellowship Program :: Graduates
Share |
Printer Friendly

2012

Erlyn Smith, M.D.
Attending Physician, Pediatric Specialist, Hematology/Oncology

Dr. Smith’s research focus was Hodgkin’s lymphoma. To determine the seasonal pattern of Hodgkin’s lymphoma among young adults using data from California Cancer Registry. She has published ‘Association between Insurance and Socioeconomic Status and Risk of Advanced Stage Hodgkin Lymphoma in Adolescents and Young Adults’ Cancer 2012

 Nick Park, M.D.
Attending Physician/Asst. Professor, University of Maryland, Pediatric Hematology/Oncology

Dr. Park’s focus was to understand the effects of Hydroxyurea (HU) on the Sickle Cell membrane proteome via tandem MS as the primary methodology for protein identification. ‘Hydroxyurea Up-regulates Voltage-Dependent Anion Channels in Human Sickle Erythrocytes’ Abstract American Society of Hematology Annual Meeting, 2012 Atlanta

2011

David Shyr, M.D.
Attending Physician, BMT Program, All Children’s Outpatient Care Center

Dr. Shyr’s research focus was in the area of TCF-1 Isoform Expression and Wnt Signaling Pathway in T-Cell ALL “Effect of immune therapy on PNH clone size and bone marrow cellularity”, Abstract Annual Meeting of the American Society of Pediatric Hematology/Oncology, Montréal, Canada, 2010.

2010

Van Huynh, M.D.
Attending Physician, Children’s Hospital of Orange Co.

Dr. Huynh focused her research on two areas of Wilms’ Tumor. 1. Epidemiology & clinical characteristics of Wilms’ tumor in California. 2. Risk factors for Wilms’ Tumor. “The Epidemiology and Clinical Characteristics of Wilms Tumor in California” Abstract, American Association for Cancer Research 100th annual conference, 2009.

2009

David Simon, M.D.
Attending PhysicianMillers Children’s Hospital

Dr. Simon had the opportunity to focus his research on mutations of the tumor suppressor p53 .  Publication of this research has been submitted.  Also interested in platelet dysfunction, he has published an article entitled “Platelet function defects” in Haemophilia.

2008

Elyssa Rubin, M.D.
Attending Physician Children’s Hospital of Orange County

Dr. Rubin’s research goal was to understand the underlying mechanisms of tumor progression in Osteosarcoma in order to define targets for novel therapies.  This research was published in Molecular Cancer Therapy.

2007

Loan Bui-Hsieh, M.D.
Attending Physician, Children’s Hospital of Orange Co.

Dr. Hsieh’s primary research project in Factor XIII began with a question in molecular genetics.  Factor XIII has several common polymorphisms often known as single nucleotide polymorphisms (SNPs) that occur in the normal population. Her research studied the effects of these SNPs on clot dynamics as measured by thromboelastrography.

Amit Soni, M.D.
Attending Physician – Children’s Hospital of Orange Co.

Dr. Soni conducted a Phase I clinical, randomized, double-blind, cross-over study to assess safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A patients.  He is a leading member of our Hematology clinical trials and has a special interest in Hemophilia studies.

2005

Amy Lovejoy, M.D.
Director, Hemophilia Treatment Center Rady’s Children’s Hospital

Dr. Lovejoy’s research included a clinical trial of recombinant factor XIII in patients with factor XIII deficiency. She also performed several related projects. She was awarded a Bayer Fellowship Grant. Her research project has been accepted for publication in Blood.

2000

Jorge DiPaola, M.D.
Associate Professor of Pediatrics and Genetics
The Postle Family Chair in Pediatric Cancer and Blood Disorders
University of Colorado, The Children's Hospital

Dr. DiPaola’s research involved determining the effect of platelet glycoprotein polymorphisms on the bleeding manifestations in patients with type 1 von Willebrand disease. This research was published in Blood. He currently is a leading expert on the genetics of von Willebrand disease.

1999

Ivan Kirov, M.D.
Director, Recurrent Cancer Program
Attending physician Children’s Hospital of Orange County

Amal Abu-Ghosh, MBBS
Georgetown University

Francisco Bracho, M.D.
Georgetown University

1997

Robert Sweetman, M.D.
Vice President, Global Affairs, Wyeth Pharmaceutical

Tulika Seth, M.D.
All India Institute of Medical Sciences, Dept. of Pediatrics/Div. of Pediatric Hematology/Oncology New Dehli, India

1995

Joseph Rosenthal, M.D.
Director - Pediatric Bone Marrow Transplant Program
City of Hope Hospital, Duarte, CA

1993

Eileen R. Gillian, M.D.
Assistant Professor of Pediatrics, University of
Connecticut Medical Center, Department of Pediatric Hematology/Oncology

*Due to changes in the pediatric hematology/oncology program at CHOC, there were no fellows in 2001-2002.
 

HEM/ONC FELLOWSHIP
ROTATIONS
SALARY & BENEFITS
GRADUATES
RELATED HEALTH TOPICS:
ONCOLOGY
HEALTH TOPICS A-Z
CENTERS:
RESEARCH INSTITUTE
HYUNDAI CANCER INSTITUTE
RELATED SERVICES:
HEM/ONC FELLOWSHIP
RELATED SPECIALTIES:
HEMATOLOGY
ONCOLOGY
RELATED LINKS:
FIND SPECIALISTS
ARTICLES
STORIES
NEWS
VIDEO
spacer

Facebook  Twitter  Pinterest  Instagram  Foursquare  LinkedIn  YouTube  RSS  CHOC Blog

US News     CAPE Award   Magnet      Beacon Award      Most Trusted Brand     Leapfrog

chocChildren's Hospital of Orange County | UCI University of California, Irvine

Children's Hospital of Orange County is affiliated with UC Irvine Healthcare and UC Irvine School of Medicine

CHOC Children's - 1201 W La Veta Ave, Orange, CA. Phone: 714-997-3000. .